Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Mouret

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Annales De Chirurgie|January 1, 1993
[Celioscopic surgery and law about the protection of persons in biomedical research]P Testas, M A Bruhat, F Dubois, et al.
Journal Francais D'Ophtalmologie|January 3, 2021
Evaluation of ostium size following endoscopic dacryocystorhinostomy as a predictive factor of outcome: A prospective studyP-J Bertaux, G Gan, G Hirtz, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|May 11, 2005
[Tako-tsubo: a rare form of transient left ventricular dysfunction]F Barbou, T Hovasse, T Cuisset, et al.
Journal of Thrombosis and Haemostasis : JTH|March 21, 2012
Semuloparin for prevention of venous thromboembolism after major orthopedic surgery: results from three randomized clinical trials, SAVE-HIP1, SAVE-HIP2 and SAVE-KNEEM R Lassen, W Fisher, P Mouret, et al.
The Bone & Joint Journal|March 30, 2013
Extended venous thromboembolism prophylaxis in patients undergoing hip fracture surgery - the SAVE-HIP3 studyW D Fisher, G Agnelli, D J George, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|February 17, 2006
[Endomyocardial fibrosis: a rare case of restrictive cardiomyopathy in a Caucasian female]T Cuisset, L Nait Saidi, J P Mouret, et al.
The New England Journal of Medicine|November 14, 1997
A comparison of recombinant hirudin with a low-molecular-weight heparin to prevent thromboembolic complications after total hip replacementB I Eriksson, P Wille-Jørgensen, P Kälebo, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|November 15, 2006
[Beneficial effect of a loading dose of 600 mg of clopidogrel on platelet parameters in patients admitted for acute coronary syndrome]T Cuisset, C Frère, J Quilici, et al.
Thrombosis Research|May 20, 2008
Safety assessment of new antithrombotic agents: lessons from the EXTEND study on ximelagatranG Agnelli, B I Eriksson, A T Cohen, et al.
Journal of Thrombosis and Haemostasis : JTH|December 17, 2003
The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS studyB I Eriksson, G Agnelli, A T Cohen, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Annales De Chirurgie|January 1, 1993
[Celioscopic surgery and law about the protection of persons in biomedical research]P Testas, M A Bruhat, F Dubois, et al.
Journal Francais D'Ophtalmologie|January 3, 2021
Evaluation of ostium size following endoscopic dacryocystorhinostomy as a predictive factor of outcome: A prospective studyP-J Bertaux, G Gan, G Hirtz, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|May 11, 2005
[Tako-tsubo: a rare form of transient left ventricular dysfunction]F Barbou, T Hovasse, T Cuisset, et al.
Journal of Thrombosis and Haemostasis : JTH|March 21, 2012
Semuloparin for prevention of venous thromboembolism after major orthopedic surgery: results from three randomized clinical trials, SAVE-HIP1, SAVE-HIP2 and SAVE-KNEEM R Lassen, W Fisher, P Mouret, et al.
The Bone & Joint Journal|March 30, 2013
Extended venous thromboembolism prophylaxis in patients undergoing hip fracture surgery - the SAVE-HIP3 studyW D Fisher, G Agnelli, D J George, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|February 17, 2006
[Endomyocardial fibrosis: a rare case of restrictive cardiomyopathy in a Caucasian female]T Cuisset, L Nait Saidi, J P Mouret, et al.
The New England Journal of Medicine|November 14, 1997
A comparison of recombinant hirudin with a low-molecular-weight heparin to prevent thromboembolic complications after total hip replacementB I Eriksson, P Wille-Jørgensen, P Kälebo, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|November 15, 2006
[Beneficial effect of a loading dose of 600 mg of clopidogrel on platelet parameters in patients admitted for acute coronary syndrome]T Cuisset, C Frère, J Quilici, et al.
Thrombosis Research|May 20, 2008
Safety assessment of new antithrombotic agents: lessons from the EXTEND study on ximelagatranG Agnelli, B I Eriksson, A T Cohen, et al.
Journal of Thrombosis and Haemostasis : JTH|December 17, 2003
The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS studyB I Eriksson, G Agnelli, A T Cohen, et al.
Pageof 4